[Effects of glucofuranoside on the isolated strips of veins].
D000818:Animals; D001158:Arteries / Q000187:drug effects; D001464:Barium / Q000037:antagonists & inhibitors; D001593:Benzyl Compounds / Q000494:pharmacology*; D001920:Bradykinin / Q000037:antagonists & inhibitors; D002118:Calcium / Q000037:antagonists & inhibitors; D004285:Dogs; D005260:Female; D005947:Glucose / Q000037:antagonists & inhibitors / Q000494:pharmacology; D006027:Glycosides / Q000494:pharmacology*; D006633:Histamine Antagonists; D066298:In Vitro Techniques; D008251:Macaca; D008297:Male; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D010208:Papaverine / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D011188:Potassium / Q000037:antagonists & inhibitors; D011817:Rabbits; D012702:Serotonin Antagonists; D012964:Sodium / Q000037:antagonists & inhibitors; D013552:Swine; D013779:Tetrodotoxin / Q000494:pharmacology; D014680:Veins / Q000187:drug effects*
D001593:Benzyl Compounds; D006027:Glycosides; D006633:Histamine Antagonists; D012702:Serotonin Antagonists; D001464:Barium; D013779:Tetrodotoxin; D012964:Sodium; D010208:Papaverine; D010653:Phenylbutazone; D005947:Glucose; D011188:Potassium; D001920:Bradykinin; D002118:Calcium; D009638:Norepinephrine